Promedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association

Press/Media: Press / Media

PeriodJun 4 2015

Media coverage

34

Media coverage

  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletCNBC
    CountryUnited States
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletReuters
    CountryUnited Kingdom
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletBloomberg
    CountryUnited States
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletBusiness Wire
    CountryUnited States
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletPharmiWeb
    CountryUnited Kingdom
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletFat Pitch Financials
    CountryUnited States
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletRCL Advisors
    CountryUnited States
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletMarketplace
    CountryUnited States
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletFranklin Credit Management Corporation
    CountryUnited States
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletEON: Enhanced Online News
    CountryUnited States
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletSearchBug
    CountryUnited States
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletBioSpace
    CountryUnited States
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletMoneyShow.com
    CountryUnited States
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletTown Hall
    CountryUnited States
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletPettinga Financial Advisors
    CountryUnited States
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletReliance Trust
    CountryUnited States
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletCrawford Financial Planning
    CountryUnited States
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletFinancial Content
    CountryUnited States
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletMarket Pulse Navigator
    CountryUnited States
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletWall Street Select
    CountryUnited States
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletCEOWorld Magazine
    CountryUnited States
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletWall Street Business Network
    CountryUnited States
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletIndustrial Info Financials
    CountryUnited States
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletYahoo! UK and Ireland
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletFreshnews.com
    CountryUnited States
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletTamar Securities
    CountryUnited States
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outlet4 Traders
    CountryUnited States
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletPharmacy Choice
    CountryUnited States
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletGood Day Sacramento
    CountryUnited States
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletAsk.com
    CountryUnited States
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletStock Nod
    CountryUnited States
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletMyrtle Beach Sun News
    CountryUnited States
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletFinanzNachrichten.de
    CountryGermany
    Date6/4/15
    PersonsRuben Mesa
  • TitlePromedior Announces Presentation of Additional Positive Phase 2 Data on PRM-151 in Myelofibrosis at the Upcoming Congress of the European Hematology Association
    Media name/outletBioPortfolio
    CountryUnited Kingdom
    Date6/4/15
    PersonsRuben Mesa